The National Heart, Lung and Blood Institute (NHLBI) of the U.S. National Institutes of Health (NIH) has awarded VESTECK Inc. a Direct to Phase II SBIR Grant to support the pre-market development and clinical validation of the Suture-Tight™ Endovascular Suturing device (Award Number R44HL178318). This grant, totaling $1.98M, is broken…
Read More
"Sean Lyden MD, Professor and Chairman Vascular Surgery Cleveland Clinic on the mainstage at ISET 2024" See more here
Read More
VESTECK, Inc. "it is always someone's mom or dad, brother or sister." See more here
Read More
VESTECK Scientific Advisory Board members address significant global unmet need See more here
Read More
VESTECK , Inc. is excited to announce that the U.S. Patent Application No. 17/841,373 Title: REMOTE SURGICAL SUTURE SYSTEM, has been allowed by the U.S. Patent and Trademark Office (USPTO) See more here
Read More
VESTECK Continues to Help Patients Around the World See more here
Read More
VESTECK SAB Member Accepts International Leadership Appointment See more here
Read More
"Vesteck, Inc. Successfully Completes Five Clinical Cases" See more here
Read More
VESTECK, Inc. is pleased to announce the first in human use of several SUTURE-TIGHT devices See more here
Read More
Dr. Sean Lyden Agrees to Assume the Role of Chief Medical Consultant and Join the VESTECK Scientific Advisory Board See more here
Read More